← Studies Suggest 🏥 Health

Appendicitis Doesn't Mean Automatic Surgery Anymore. A 10-Year Trial Found 56% of Patients Kept Their Appendix With Less Than One-Third the Complications

For over a century, appendicitis meant emergency surgery. The longest randomized follow-up ever run tracked 530 Finnish patients for ten years and found antibiotics-first spared 56% the operation entirely, with far fewer complications and identical quality of life.

By James Marchetti, Health & Medicine · September 27, 2026

In 1889, the surgeon Charles McBurney described the operation that made his name: open the abdomen, tie off the appendix, remove it. Before him, appendicitis was often a death sentence. A burst appendix spilled bacteria into the abdominal cavity, and peritonitis finished the job. McBurney's appendectomy turned a lethal emergency into a routine cure, and the logic hardened into reflex. Roughly 300,000 Americans still undergo appendectomy every year, and the emergency-room script has barely changed in 137 years: diagnose appendicitis, remove the appendix, preferably tonight, because the organ will burst and antibiotics cannot fix a plumbing problem. That was the dogma.

Paulina Salminen's team at the University of Turku decided to test the reflex. Their APPAC trial randomized 530 adults with CT-confirmed uncomplicated appendicitis, meaning no perforation, no abscess, and no appendicolith, to either standard open appendectomy or ten days of antibiotics: three days of intravenous ertapenem followed by a week of oral levofloxacin and metronidazole. The original 2015 results were provocative but inconclusive, because nearly three-quarters of the antibiotics group avoided surgery at one year, yet the trial failed its own prespecified noninferiority test, so the team kept watching. They watched for ten years. In January 2026, JAMA published the ten-year follow-up, the longest randomized look at this question ever assembled, with 98.4 percent of the antibiotics group still accounted for.

After a full decade, the cumulative appendectomy rate in the antibiotics group was 44.3 percent. True recurrence, confirmed by examining removed tissue under a microscope rather than trusting symptoms alone, was 37.8 percent, with most failures clustering in the first year after treatment. Put plainly: 56 percent of patients kept their appendix and never needed the operation. The complication ledger is where the story gets uncomfortable for surgery. Over ten years, 27.4 percent of the appendectomy group experienced a complication, including wound infections, hernias, persistent abdominal pain, and bowel-obstruction symptoms, against 8.5 percent of the antibiotics group. That gap translates to roughly one complication avoided for every five or six patients treated antibiotics-first. Quality of life, measured on the standard EQ-5D scale, was indistinguishable a decade out, with both groups rating their health at the maximum. The surgery group also logged eleven more days of sick leave, a difference recorded at the five-year mark.

The American CODA trial, 1,552 patients at 25 medical centers whose results appeared in the New England Journal of Medicine in 2020, independently found antibiotics noninferior on 30-day quality of life, with 29 percent needing surgery by 90 days and just under half by four years. A French trial in the Lancet, Swedish trials, and multiple meta-analyses point the same way. Following the CODA results, the American College of Surgeons rewrote its guidance: antibiotics are now an accepted first-line treatment for most patients with uncomplicated appendicitis, which makes the emergency-surgery reflex officially optional. The default flipped.

Nobody has scaled these numbers to a population, so here is the arithmetic the paper leaves out. Suppose 300,000 Americans undergo appendectomy each year and two-thirds have the uncomplicated kind eligible for antibiotics-first. If the Finnish numbers travel, with 56 percent avoiding surgery over a decade, that is roughly 110,000 operations not performed every year. Price an appendectomy at a conservative $12,000 against a few hundred dollars of antibiotics, and the avoided procedures represent on the order of a billion dollars annually, before counting the eleven sick days per patient the surgery group lost. These are back-of-the-envelope figures with real uncertainty: Finnish open appendectomy in 2009 is not American laparoscopic surgery in 2026, and eligibility is narrower than two-thirds. But the direction is unambiguous. The trials never quite state it, but a large share of the most common emergency operation in medicine may be elective.

The Strongest Counterargument

The strongest objection is not that the data are wrong but that the headline version oversells them, so start with the fine print the enthusiasts skip: the original 2015 APPAC trial failed its prespecified noninferiority test, which means antibiotics did not clear the bar the investigators themselves set. Then there is the 44.3 percent. The glass-half-empty reading says antibiotics-first is slow-motion surgery for nearly half of patients, who endure years of recurrence anxiety and get operated on anyway. The subgroup data sharpen the objection, because in CODA, patients with an appendicolith, a calcified stone lodged in the appendix that shows up in about a quarter of cases, fared markedly worse on antibiotics: 41 percent needed surgery within 90 days, with complication rates far above the surgery group, so for them the "choice" looks like a bad bet, and Salminen herself insists the two conditions are different diseases rather than points on a spectrum, which matters because CT is not perfect and some patients labeled uncomplicated are carrying complicated disease into an antibiotics-first plan. Finally there is the cost nobody measured, because ten days of broad-spectrum antibiotics is not free: it perturbs the gut microbiome, and it spends antibiotic effectiveness, a shared resource, to avoid an operation that modern laparoscopic surgery makes safe and definitive.

What We Didn't Prove

Be honest about the boundaries. The ten-year data are observational follow-up of a randomized trial rather than a fresh randomization, and telephone-based ascertainment introduces noise that a clinic visit would not. The patients were Finnish adults aged 18 to 60 with CT-confirmed uncomplicated appendicitis, which excludes children, the elderly in whom appendiceal tumor risk is highest, and anyone presenting with perforation, abscess, or appendicolith. The surgical comparator was open appendectomy, the 2009 standard, while today's laparoscopic operation causes fewer wound infections and would narrow the complication gap if the trial ran now. The tumor question was addressed by a post-hoc MRI amendment at ten years rather than by the original design, which is reassuring, with a 0.9 percent neoplasm rate and every case detected, but not the same as a prespecified cancer endpoint. And the Finnish numbers may not travel, because American patients, American surgeons, and American antibiotic regimens all differ from the ones in Turku.

The Bottom Line

Two facts now coexist, and they are not in conflict. Appendicitis can kill, and delayed treatment of the complicated kind remains dangerous, but for the common, uncomplicated kind, the automatic trip to the operating room is a habit rather than a necessity. Ten years of randomized evidence say a course of antibiotics cures most patients, harms fewer, and leaves them exactly as healthy. The appendix, it turns out, was never the emergency. The assumption was.

What You Can Do

If appendicitis strikes, ask the question the trials made legitimate: is this uncomplicated? Ask specifically about the CT findings: perforation, abscess, and above all appendicolith, the stone that makes antibiotics-first a poor bet. Know that the American College of Surgeons now endorses antibiotics as a first-line option, so requesting shared decision-making is not contrarian, and a patient decision aid exists at appyornot.org. Do not confuse this with staying home, because the trials tested treatment choice after prompt diagnosis, and waiting turns uncomplicated appendicitis into the complicated kind that takes antibiotics off the table. And if you choose the pills, go in with the real odds: roughly a 44 percent chance of eventual surgery over ten years, most of it in the first year, with the reassurance that a later operation, when needed, proved just as safe.